132 related articles for article (PubMed ID: 27639973)
1. Isolation of alpha-linolenic acid from Sutherlandia frutescens and its inhibition of Mycobacterium tuberculosis' shikimate kinase enzyme.
Masoko P; Mabusa IH; Howard RL
BMC Complement Altern Med; 2016 Sep; 16():366. PubMed ID: 27639973
[TBL] [Abstract][Full Text] [Related]
2. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
3. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating polysaccharides from Lessertia frutescens leaves: isolation, characterization and structure activity relationship.
Zhang B; Leung WK; Zou Y; Mabusela W; Johnson Q; Michaelsen TE; Paulsen BS
J Ethnopharmacol; 2014 Mar; 152(2):340-8. PubMed ID: 24480566
[TBL] [Abstract][Full Text] [Related]
5. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
6. Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism.
Müller AC; Patnala S; Kis O; Bendayan R; Kanfer I
J Pharm Pharm Sci; 2012; 15(2):221-33. PubMed ID: 22579002
[TBL] [Abstract][Full Text] [Related]
7. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
[TBL] [Abstract][Full Text] [Related]
8. Comparative cardio and developmental toxicity induced by the popular medicinal extract of Sutherlandia frutescens (L.) R.Br. detected using a zebrafish Tuebingen embryo model.
Chen L; Xu M; Gong Z; Zonyane S; Xu S; Makunga NP
BMC Complement Altern Med; 2018 Oct; 18(1):273. PubMed ID: 30290800
[TBL] [Abstract][Full Text] [Related]
9. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase.
Rahul Reddy MB; Krishnasamy SK; Kathiravan MK
Bioorg Chem; 2020 Sep; 102():104083. PubMed ID: 32745735
[TBL] [Abstract][Full Text] [Related]
11. Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pinto CA; Basso LA; Santos DS
Protein Expr Purif; 2001 Aug; 22(3):430-5. PubMed ID: 11483005
[TBL] [Abstract][Full Text] [Related]
12. The apoptosis inducing effects of Sutherlandia spp. extracts on an oesophageal cancer cell line.
Skerman NB; Joubert AM; Cronjé MJ
J Ethnopharmacol; 2011 Oct; 137(3):1250-60. PubMed ID: 21824511
[TBL] [Abstract][Full Text] [Related]
13. Sutherlandia frutescens prevents changes in diabetes-related gene expression in a fructose-induced insulin resistant cell model.
Williams S; Roux S; Koekemoer T; van de Venter M; Dealtry G
J Ethnopharmacol; 2013 Mar; 146(2):482-9. PubMed ID: 23376105
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial and antioxidant activity of Sutherlandia frutescens (Fabaceae), a reputed anti-HIV/AIDS phytomedicine.
Katerere DR; Eloff JN
Phytother Res; 2005 Sep; 19(9):779-81. PubMed ID: 16220570
[TBL] [Abstract][Full Text] [Related]
16. Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells.
Chinkwo KA
J Ethnopharmacol; 2005 Apr; 98(1-2):163-70. PubMed ID: 15763378
[TBL] [Abstract][Full Text] [Related]
17. Sutherlandia frutescens modulates adrenal hormone biosynthesis, acts as a selective glucocorticoid receptor agonist (SEGRA) and displays anti-mineralocorticoid properties.
Sergeant CA; Africander D; Swart P; Swart AC
J Ethnopharmacol; 2017 Apr; 202():290-301. PubMed ID: 28323049
[TBL] [Abstract][Full Text] [Related]
18. Impact of traditional medicinal plant extracts on antiretroviral drug absorption.
Brown L; Heyneke O; Brown D; van Wyk JP; Hamman JH
J Ethnopharmacol; 2008 Oct; 119(3):588-92. PubMed ID: 18640255
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus.
Harnett SM; Oosthuizen V; van de Venter M
J Ethnopharmacol; 2005 Jan; 96(1-2):113-9. PubMed ID: 15588658
[TBL] [Abstract][Full Text] [Related]
20. The influence of Sutherlandia frutescens on adrenal steroidogenic cytochrome P450 enzymes.
Prevoo D; Swart P; Swart AC
J Ethnopharmacol; 2008 Jun; 118(1):118-26. PubMed ID: 18485640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
